The role of multifunctional delivery scaffold in the ability of cultured myoblasts to promote muscle regeneration.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 21911253.
- Also identified by DOI 10.1016/j.biomaterials.2011.08.019 and PMC identifier 3210474.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Many cell types of therapeutic interest, including myoblasts, exhibit reduced engraftment if cultured prior to transplantation. This study investigated whether polymeric scaffolds that direct cultured myoblasts to migrate outwards and repopulate the host damaged tissue, in concert with release of angiogenic factors designed to enhance revascularizaton of the regenerating tissue, would enhance the efficacy of this cell therapy and lead to functional muscle regeneration. This was investigated in the context of a severe injury to skeletal muscle tissue involving both myotoxin-mediated direct damage and induction of regional ischemia. Local and sustained release of VEGF and IGF-1 from macroporous scaffolds used to transplant and disperse cultured myogenic cells significantly enhanced their engraftment, limited fibrosis, and accelerated the regenerative process. This resulted in increased muscle mass and, improved contractile function. These results demonstrate the importance of finely controlling the microenvironment of transplanted cells in the treatment of severe muscle damage.
Medical subject headings
- Insulin-Like Growth Factor I
- Muscle, Skeletal
- Myoblasts
- Regeneration
- Tissue Scaffolds
- Vascular Endothelial Growth Factor A